Lona Fowdur is an economist and testifying expert with more than fifteen years of experience analyzing antitrust issues in healthcare, energy and other sectors. She has been recognized as a leading expert by Lexology/Who’s Who Competition for the past eight years.
Dr. Fowdur has investigated the competitive effects of horizontal and vertical mergers between hospitals, physician groups, pharmaceutical benefit managers, and health insurance companies. She has testified on behalf of the parties in a high-profile insurance-company merger trial and provided expert witness testimony in pharmaceutical class-action cases involving allegations of anticompetitive reverse payments and product-hopping. She has provided expert reports and economic testimony to arbitration panels and to state regulatory agencies and has served as a consultant to a state Attorney General’s office on competition matters.
Dr. Fowdur has also worked on electric utility mergers, allegations of exercise of market power, investigations of exclusionary practices, market-based rate filings, and other regulatory conduct investigations. Dr. Fowdur has investigated the design of capacity auctions within RTOs, transmission cost allocation issues, allegations of anticompetitive conduct during the California energy crisis, the extent of forward hedging by electric utilities, the outcomes of rate cases of interstate natural gas pipelines, and the impact of coal retirements on market structure.
Dr. Fowdur has written several articles and has spoken on ABA and AHLA panels regarding the economics of healthcare transactions, econometric tools of competition analysis, cross-market provider mergers, and physician practice acquisitions. She has also served as the chair of the AHLA’s Antitrust Practice Group.
Dr. Fowdur has a Ph.D. in Economics from Cornell University and undergraduate degrees in finance and economics from the University of Adelaide in Australia. She is originally from Mauritius and is fluent in French and Hindi.